Floatz logo

Therapeutic Asset Ratings

200 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dasatinib
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Ruijin HospitalP1/2CC (43)
Sonrotoclax
Large B-Cell Lymphoma
Ruijin HospitalP1/2CC (43)
BMS-986345
Diffuse Large B Cell Lymphoma
Ruijin HospitalP1CC (42)
Duvelisib
Diffuse Large B-Cell Lymphoma
Ruijin HospitalP1CC (42)
abo2203
B-Cell Non-Hodgkin Lymphoma
Ruijin HospitalP1CC (41)
Anti-Meso Car T Cells
Refractory Malignant Neoplasm
Ruijin HospitalP1CC (41)
Lcar-Hl30 Cells
Anaplastic Large Cell Lymphoma
Ruijin HospitalP1CC (41)
ntf001
ALS (Amyotrophic Lateral Sclerosis)
Ruijin HospitalP1CC (41)
pd-1 knockout engineered t cells
Autosomal Dominant Parkinson Disease 1
Ruijin HospitalP1CC (41)
pd1-til
Autosomal Dominant Parkinson Disease 1
Ruijin HospitalP1CC (41)
Spartalizumab
Parkinson Disease
Ruijin HospitalP1CC (40)
pd-1 knockout engineered t cells
Colorectal Cancer
Ruijin HospitalP1C (39)
pd1-til
Colorectal Cancer
Ruijin HospitalP1C (39)
Clozapine
Gene Therapy
Ruijin HospitalEarly P1C (39)
Clozapine
Safety and Efficacy
Ruijin HospitalEarly P1C (39)
Personalized Neoantigen Tumor Vaccine
Chemotherapy-intolerant
Ruijin HospitalEarly P1C (39)
abo2102
Other Solid Tumors
Ruijin HospitalEarly P1C (38)
abo2102
Pancreatic Neoplasm
Ruijin HospitalEarly P1C (38)
Personalized Neoantigen Tumor Vaccine
Malignant Pancreatic Neoplasm
Ruijin HospitalEarly P1C (38)
Personalized Neoantigen Tumor Vaccine
Pancreatic Adenocarcinoma
Ruijin HospitalEarly P1C (38)
Toripalimab
Other Solid Tumors
Ruijin HospitalEarly P1C (38)
Hekt Cell
Non-Small Cell Lung Carcinoma
Ruijin HospitalP1C (37)
Clozapine
Parkinson Disease
Ruijin HospitalEarly P1C (37)
ABO2109
Solid Tumor
Ruijin HospitalEarly P1C (33)
es502
Pancreatic Neoplasm
Ruijin HospitalEarly P1C (33)
Showing 151 to 175 of 200 assets
PreviousPage 7 of 8Next